AllianceBernstein’s Bioverativ Inc. Common Stock BIVV Stock Holding History

AllianceBernstein’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-74,666	Closed	-$4.03M	–	3080
2017 Q4	$4.03M	Sell	74,666 -1,182	-2%	-$64.7K	﹤0.01%	1358
2017 Q3	$4.33M	Sell	75,848 -13,174	-15%	-$772K	﹤0.01%	1305
2017 Q2	$5.36M	Sell	89,022 -1,872	-2%	-$107K	﹤0.01%	1180
2017 Q1	$4.95M	Buy	+90,894	New	+$4.48M	﹤0.01%	1195

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

AllianceBernstein's BIVV Position: Q1 2018 in Review

AllianceBernstein sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 74,666 shares — an estimated $4.03M sold.

AllianceBernstein first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $5.36M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

AllianceBernstein reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
AllianceBernstein sold 74,666 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $4.03M.
AllianceBernstein first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
AllianceBernstein's Bioverativ Inc. Common Stock position peaked at $5.36M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on AllianceBernstein's 13F filing for Q1 2018, filed 14 May 2018.